Pt(R,R-DACH)(DMC)

**Pt(R,R-DACH)(DMC)** is a platinum-based coordination complex, where "Pt" refers to platinum, "(R,R-DACH)" denotes the chiral ligand R,R-1,2-diaminocyclohexane, and "(DMC)" is an abbreviation likely representing an organic ligand coordinated to the platinum, though the exact chemical identity of DMC is unclear from search results. Such platinum complexes are relevant to the field of anticancer research, as analogues of oxaliplatin and other platinum drugs, and are investigated for their cytotoxic activities against cancer cells. The mechanism of action of platinum-DACH compounds is typically through binding to DNA, causing inter- and intra-strand DNA crosslinks, which leads to the inhibition of DNA replication and transcription, ultimately resulting in cancer cell apoptosis. The developer, manufacturer, and precise disease targets for the compound Pt(R,R-DACH)(DMC) cannot be determined from the available information.